Puma Biotechnology Presents Data from the Neratinib Arm of the INSIGhT Trial at the 2021 SNO Annual Meeting

LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology will present data from the neratinib arm of the Phase II INSIGhT Trial at the 2021 Society for Neuro-Oncology Annual Meeting (SNO),

Click to view original post